Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyzed Transfer Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110483420B details a novel Rh-catalyzed reduction of quinoxalines using water as a hydrogen source, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.
Novel water-based hydrogenation method reduces costs and simplifies purification for high-purity tetrahydroquinoxaline pharmaceutical intermediates.